Statistical Programming

When you require accurate and efficient statistical programming CRO services, MMS is your first choice.

When faced with an urgent delivery, MMS knocked it out of the park. This Biometrics team is one of the best I’ve worked with.
Head of Biometrics
Large Pharma Sponsor

Sponsors come to MMS statistical programming experts for three things: accuracy, innovation, and knowledge. A deep bench ensures that knowledge flows throughout the project team and cross-functionally for strong datasets, analyses, and other outputs. Resulting from this is fewer drafts, a smoother review process, and time saved for every Sponsor.

Programming Innovation & Quality
Along with expertise in SAS & R our experienced team has the advantage of proprietary tools and AI, to aid in the efficiency and automation of programming deliverables.
 
Complete Support
Comprehensive support across the entire drug development lifecycle, including Phase I-IV clinical trials, 120-day safety updates, AD-Hoc requests, HTA, RWE, BIMO, integrated summary of Safety/Efficacy (ISS/ISE, data anonymization), and SEND datasets.
 
Data Integration & Standardization
Creation of CDISC compliant SDTM/ADaM datasets and specifications, including legacy data conversion to industry standards and up-compliance for legacy data if needed. Creation of analysis tables, listings, and figures (TLFs), planned, ad-hoc, and/or rescue to the highest standards.
 
Submission Readiness         
Submission readiness for the creation of submission-ready datasets and specifications, annotated CRFs, define files, and reviewers’ guides.

Services Provided
  • Creation of CDISC-compliant SDTM and ADaM datasets
  • Generate planned and ad-hoc analysis TLFs
  • Data anonymization
  • SEND dataset and submission package support as per FDA requirement
  • Development of submission ready define files, reviewers guide
  • Support and recommendation for Bioresearch Monitoring (BIMO) package
  • Validation and gap analyses
  • Data Safety Monitoring Board (DSMB) support, Development Safety Update Report (DSUR) support, advisory committees, and IND reporting
  • Open communication within and across functions driving higher levels of success
Immutable Tables

MMS programmers using proprietary technology are proficient at creating immutable tables which have several in-text applications for the MMS writing team and sponsors including but not limited to:

  • increased efficiency and quality
  • streamlined QC processes, and
  • early messaging discussions, among others.
Exceptional Quality & Efficiency

At MMS, every programmed deliverable (e.g. dataset, TFL, documentation) follows a three-phase process of quality control, validation and assurance, ensuring that we deliver to the highest standards.Exceptional Quality & Efficiency

Rescue Studies

MMS Statistical programming is specialized in the review and assessment of all study elements and identifying key issues that could be preventing study success.

Study rescue plans focus on resolving current bottlenecks and study challenges by introducing new strategies, such as expediting study schedules or finding other solutions to regain time and momentum.

Rescue studies are often challenging for any CRO, but MMS has been trusted with a considerable number of rescue studies by its sponsors with consistent success.

Suggested For You

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry